NCT04427163 Assesment of Multiomics Profiles in Health and Disease.
| NCT ID | NCT04427163 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Institute of Molecular and Translational Medicine, Czech Republic |
| Condition | Genetic Predisposition to Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,100 participants |
| Start Date | 2018-09-01 |
| Primary Completion | 2028-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,100 participants in total. It began in 2018-09-01 with a primary completion date of 2028-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will determine reference genomic, transcriptomic, proteomic and metabolomic profiles in Czech population and will evaluate its correlation with the disease phenotype.
Eligibility Criteria
Inclusion Criteria: * age 18 - 68 years * (for the first 1100 subjects): * healthy volunteers without genetically dependent disease and without such a disease in a family * healthy volunteer without the preliminary evidence of civilizational diseases such as hypertension, diabetes, autoimmune and tumor diseases or acute infectional diseases; clinically manifesting cardiovascular or pulmonary disability. * subject without permanent of long-term medication in the time of biological sampling. Exclusion Criteria: * not complying with inclusion criteria
Contact & Investigator
Marian Hajduch, MD, PhD.
STUDY DIRECTOR
IMTM, Palacky University in Olomouc, Faculty of Medicine and Dentistry
Frequently Asked Questions
Who can join the NCT04427163 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 68 Years, studying Genetic Predisposition to Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04427163 currently recruiting?
Yes, NCT04427163 is actively recruiting participants. Contact the research team at marian.hajduch@upol.cz for enrollment information.
Where is the NCT04427163 trial being conducted?
This trial is being conducted at Olomouc, Czechia.
Who is sponsoring the NCT04427163 clinical trial?
NCT04427163 is sponsored by The Institute of Molecular and Translational Medicine, Czech Republic. The principal investigator is Marian Hajduch, MD, PhD. at IMTM, Palacky University in Olomouc, Faculty of Medicine and Dentistry. The trial plans to enroll 1,100 participants.